Shilpa Medicare to acquire 30.4% stake in Spain's Gate2Brain with €7 million investment
Shilpa Medicare, through its subsidiary Shilpa Biologicals, plans to acquire a 20% stake in Spain-based Gate2Brain for €7 million. This strategic investment aims to advance drug delivery platforms, specifically for Central Nervous System (CNS) disorders.
Jun 03 2026 10:31:57
Shilpa Medicare Ltd - 530549 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Shilpa Medicare's wholly-owned subsidiary, Shilpa Biocare Pvt Ltd, has formed a strategic equity partnership with Gate2Brain, a Barcelona-based biotechnology company. The partnership involves an investment of €7 million for a 30.4% equity stake, focusing on developing peptide-based delivery systems for CNS diseases, including brain cancer.
Jun 03 2026 09:29:31
Shilpa Medicare Ltd - 530549 - USFDA Inspection Of Shilpa Medicare Ltd At Unit VI, Dabaspet, Bengaluru
Shilpa Medicare's Dabaspet unit underwent a USFDA Pre-Approval Inspection (PAI) from May 25-29, 2026, resulting in 5 procedural observations. The company stated these observations are not repeat findings and do not relate to data integrity, with no expected material impact on business.
May 30 2026 15:45:09
Shilpa Medicare Limited
Shilpa Medicare's Bengaluru Unit VI underwent a USFDA Pre-Approval Inspection, resulting in 5 procedural observations. The company stated these are not repeat or data integrity-related and anticipate no material operational impact.
May 30 2026 15:32:56
Shilpa Medicare Ltd - 530549 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Shilpa Medicare informed that the audio recording of its Q4 FY26 earnings conference call, which took place on May 22, 2026, is now available on the company's website. This allows investors and analysts to review the discussion.
May 22 2026 18:33:37
Shilpa Medicare Ltd - 530549 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Shilpa Medicare shareholders to vote on changing the registered office from Karnataka to Maharashtra via postal ballot. This strategic move aims to improve access to financial hubs and investors in Mumbai.
May 22 2026 15:11:17
Shilpa Medicare Ltd - 530549 - Board Meeting Outcome for Outcome Of The Board Meeting
Shilpa Medicare Board approved Q4 FY26 standalone and cons. results and recommended a final dividend of Re. 0.60 per share for FY26. Its subsidiaries will invest ₹4.44 crore for a 28% equity stake in Neo Green Power Project Private Limited to meet captive power needs.
May 22 2026 14:57:12
Shilpa Medicare Ltd - 530549 - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Shilpa Medicare's Board of Directors will meet on May 22, 2026, to consider and approve the audited Q4 & FY26 financial results. The board will also discuss a dividend recommendation for FY26.
May 14 2026 13:05:37
Read More